Risks vs Benefits for SGLT2 Inhibitor Medications

Health care providers should carefully assess patients with diabetes mellitus before prescribing sodium-glucose cotransporter 2 inhibitor medications and monitor for adverse effects.

Shranjeno v:
Bibliografske podrobnosti
izdano v:Fed Pract
Main Authors: Pittampalli, Shanti, Upadyayula, Satya, Mekala, Hema Madhuri, Lippmann, Steven
Format: Artigo
Jezik:Inglês
Izdano: Frontline Medical Communications Inc. 2018
Teme:
Feature Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6368009/
https://ncbi.nlm.nih.gov/pubmed/30766374
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki